Skip to main content

Chemicon International, Axordia Collaborate to Develop Antibodies From Human Embryonic Stem Cell Lines

NEW YORK, Sept. 30 (GenomeWeb News) - Serologicals announced today that its subsidiary, Chemicon International, has signed an exclusive agreement with Axordia to co-develop new antibody markers from Axordia's proprietary human embryonic stem cell lines.

 

Under terms of the agreement, Axordia will contribute its expertise and materials for antibody generation and characterization, and Chemicon will commercialize the new antibody research tools.

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.